Renaissance Technologies - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$95
+11.8%
102,552
-8.3%
0.00%
Q1 2023$85
-42.2%
111,800
+91.1%
0.00%
Q4 2022$147
-99.8%
58,500
-13.5%
0.00%
Q3 2022$94,000
+6.8%
67,600
-3.0%
0.00%
Q2 2022$88,000
+37.5%
69,700
+216.8%
0.00%
Q1 2022$64,000
+60.0%
22,000
+26.4%
0.00%
Q4 2021$40,000
-88.4%
17,400
+54.9%
0.00%
Q3 2018$346,00011,2350.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders